Search results for "slas europe 2018"
Selected Filters:
SelectScience celebrates 25 years of accelerating science
The silver anniversary marks 25 years of connecting scientific communities with trusted solutions
Results of first prospective trial using blood-based next-generation sequencing to identify candidates for treatment
Trial successfully identifies people with advanced non-small cell lung cancer for treatment with Alecensa
Trending in Cancer Research: Automated Cell Identification, Unique Culture Solutions, Nanobody Development and More
Explore the techniques and technologies that are shaping the latest advancements in cancer research
FDA approves first NGS-based companion diagnostic for RET fusion-positive non-small cell lung cancer
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
Rapid COVID-19 genome sequencing aids outbreak investigations
New Ion AmpliSeq SARS-CoV-2 Research Panel assists with contact tracing to identify coronavirus hot spots
Yamaha Motor Exhibits CELL HANDLER at U.S. Cancer Research Conference
Cell picking and imaging system by Yamaha has expanded applicability, including ex vivo tissue picking
Protein extraction from food samples with the Precellys Evolution
New research to prevent false positive test results in cannabis screening assays
Tecella Powers Nanion's SyncroPatch 384PE
Steve Rees, of AstraZeneca, Discusses Cutting-edge Technologies for Drug Target Validation
Steve Rees, Vice-President of Screening Sciences and Sample Management, Talks to Kerry Parker
Ultra-sensitive NGS-based sequencing targets mosaic disease
Leveraging duplex NGS with automated library prep, researchers move closer to developing liquid biopsy tests for rare genetic disorders
CLINCAL24: Insights from Sten Westgard on enhancing laboratory QC
As laboratories evolve, CLINICAL24 Ambassador, Sten Westgard offers strategies for maintaining excellence in laboratory quality control
Roche launches first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq
This launch represents an important step in Roche’s personalized healthcare strategy to fit treatments to patients who can benefit most from a specific medicine
Optilite® - Optimised Protein System
Binding SiteThe robust and proven analyzer from The Binding Site, bringing you a reliable and optimized solution for special protein testing.
Here's how scientists detect fake fish oil in dietary supplements
Discover how FT-IR is enabling fast identification of potentially harmful food fraud
FDA approves NGS-based companion diagnostic for previously treated IDH1-mutated cholangiocarcinoma
The CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO
Roche Announces Global Availability of Blood-Based Genomic Profiling Test, FoundationOne Liquid
New liquid biopsy test can identify 70 of the most commonly mutated genes in solid tumours, as well as microsatellite instability